Old Web
English
Sign In
Acemap
>
authorDetail
>
Chris Yan
Chris Yan
Amgen
Medicine
Placebo
Internal medicine
Osteoporosis
Bone resorption
4
Papers
112
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
46.5: Size Effect of Free-standing Micro-LEDs Grown on Large Si Substrates by MOCVD
2021
Zhenyu Jiang
Sam Hu
Liangliang Ren
Youliang Zhu
Yanhao Du
Gaige
Yan
Wei Sun
Chris Yan
Show All
Source
Cite
Save
Citations (0)
Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab
2019
Osteoporosis International
David L. Kendler
Henry G. Bone
F. Massari
Evelien Gielen
Santiago Palacios
Judy Maddox
Chris Yan
S. Yue
Rajani V Dinavahi
Cesar Libanati
Andreas Grauer
Show All
Source
Cite
Save
Citations (36)
Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass
2017
Journal of Bone and Mineral Research
Tony M. Keaveny
Daria B. Crittenden
Michael A. Bolognese
Harry K. Genant
Klaus Engelke
Beatriz Oliveri
Jacques P. Brown
Bente Langdahl
Chris Yan
A. D. Grauer
Cesar Libanati
Show All
Source
Cite
Save
Citations (50)
First-In-Human Study Of AMG 319, a Highly Selective, Small Molecule Inhibitor Of PI3Kδ, In Adult Patients With Relapsed Or Refractory Lymphoid Malignancies
2013
Blood
Mark C. Lanasa
Martha Glenn
Anthony R. Mato
Sallie D. Allgood
Susan Wong
Benny Amore
Gary D. Means
Erin Stevens
Chris Yan
Gregory Friberg
Andre Goy
Show All
Source
Cite
Save
Citations (26)
1
map